KIR2DL4 Antibodies

Santa Cruz Biotechnology delivers a wide array of KIR2DL4 monoclonal antibodies for immunology and cell signaling research. KIR2DL4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIR2DL4 is a member of the killer immunoglobulin-like receptor (KIR) family, playing a crucial role in the regulation of immune responses by modulating the activity of natural killer (NK) cells. The receptor is particularly important during pregnancy and viral infections, as it can influence maternal-fetal tolerance and the immune response to pathogens. Understanding KIR2DL4 function is essential for advancing therapeutic strategies in immunotherapy and transplantation. Research with KIR2DL4 monoclonal antibodies has revealed significant insights into NK cell regulation and immune system modulation. Investigating KIR2DL4 expression patterns helps researchers better understand immune response mechanisms. Current studies focusing on KIR2DL4 continue to uncover new aspects of immune system regulation. Santa Cruz Biotechnology monoclonal antibodies for KIR2DL4 support researchers worldwide in advancing our understanding of immune system function and regulation.